Return to search

Locus Biosciences pulls in $35m

Locus Biosciences Inc, a clinical-stage biotechnology company, has raised $35 million in funding.

Locus Biosciences Inc, a clinical-stage biotechnology company, has raised $35 million in funding. The backers include Artis Ventures, Tencent Holdings, Viking Global Investors, Johnson and Johnson Innovation – JJDC, Inc. and Discovery Innovations.

Source: Press Release